Specifically, in a study conducted on MDA-MB-231 BC cells, IL-6 protected malignant cells from chemotherapy-induced cytotoxicity and apoptosis via the involvement of the HIF-1, which regulates vital biological processes of tumour survival and progression [209]. Here, IL6 is linked to breast cancer.